Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. (Q51550699)
Jump to navigation
Jump to search
scientific article published in June 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. |
scientific article published in June 2000 |
Statements
1 reference
Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. (English)
1 reference
Gabazza EC
1 reference
Katsuki A
1 reference
Sumida Y
1 reference
Murata K
1 reference
Furuta M
1 reference
Araki-Sasaki R
1 reference
Tsuchihashi K
1 reference
Hori Y
1 reference
Yano Y
1 reference
Adachi Y
1 reference
1 June 2000
1 reference
2
1 reference
3
1 reference
189-191
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference